Breaking News Instant updates and real-time market news.

IMMU

Immunomedics

$5.98

0.18 (3.10%)

11:30
04/21/17
04/21
11:30
04/21/17
11:30

Immunomedics slides after Jefferies confirms no update at ASCO

Shares of Immunomedics (IMMU) are sliding near midday after Jefferies analyst Matthew Andrews said he has confirmed with the company that there will be no IMMU-132 update at ASCO, which will take place between June 2-6 in Chicago. NO UPDATE: Jefferies' analyst Andrews had expected Immunomedics to provide an update on IMMU-132, an ADC that contains SN-38, the active metabolite of irinotecan, approved by the U.S. Food and Drug Administration as a chemotherapeutic for patients with cancer. However, the analyst told investors in a research note that he has confirmed with the company that there will be no update at the American Society of Clinical Oncology annual meeting. Immunomedics had tentatively been targeting a LBA submission in triple-negative breast cancer but the data in the about 15 remaining patients are not mature enough at this time and would not be a meaningful update on the 85 patient update with confirmed responses in mid-January 2017, Andrews added. PRICE ACTION: In late morning trading, shares of Immunomedics have dropped 12.6% to $5.22.

IMMU Immunomedics
$5.98

0.18 (3.10%)

02/13/17
LEER
02/13/17
NO CHANGE
LEER
Outperform
New deal may add 'intriguing' asset to Seattle Genetics pipeline, says Leerink
Leerink analyst Michael Schmidt notes that Seattle Genetics (SGEN) has announced a global development and license agreement with Immunomedics (IMMU) for IMMU-132, which could potentially expand on the former's leadership position in the antibody-drug conjugate space by adding a late stage asset that has generated considerable interest based on its clinical activity seen in triple-negative breast cancer to date. The analyst reiterates an Outperform rating on Seattle Genetics' shares.
02/13/17
RBCM
02/13/17
NO CHANGE
RBCM
Seattle Genetics drug acquisition would be positive, says RBC Capital
After Seattle Genetics (SGEN) announced a global development and license agreement with Immunomedics (IMMU) for sacituzumab, RBC Capital analyst Adnan Butt says that the drug "seems approvable," given the positive data it has generated in trials involving triple negative breast cancer patients. The analyst adds that the drug significantly reduces the risk posed by the stock and could be used to treat other cancers. He notes that the deal has not yet been completed and keeps an $80 price target and an Outperform rating on the stock.
02/13/17
FBCO
02/13/17
NO CHANGE
Target $66
FBCO
Neutral
Seattle Genetics price target raised to $66 from $62 at Credit Suisse
Credit Suisse analyst Kennen MacKay raised his price target for Seattle Genetics to $66 from $62 saying he views the company's bid for Immunomedics' IMMU-132 positively. The analyst sees potential for near-term accelerated submission and potential approval in 2018 with potential for blockbuster sales. MacKay assumes a 60% probability of deal closing as Immunomedics has potential to seek additional bids. He reiterates a Neutral rating on Seattle Genetics' shares.
04/21/17
JEFF
04/21/17
NO CHANGE
JEFF
Immunomedics will not present IMMU-132 update at ASCO, says Jefferies
Jefferies analyst Matthew Andrews said he'd expected Immunomedics to provide an update on IMMU-132 at the meeting, but he has confirmed with the company that there will be no update presented at the meeting. Immunomedics shares are down nearly 14% in early trading.

TODAY'S FREE FLY STORIES

VCEL

Vericel

$6.55

0.3 (4.80%)

12:46
01/18/18
01/18
12:46
01/18/18
12:46
Hot Stocks
RTW Invesmtents reports 5.04% passive stake in Vericel »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

DDAIF

Daimler AG

$90.67

0.17 (0.19%)

12:45
01/18/18
01/18
12:45
01/18/18
12:45
Periodicals
Daimler, Bosch suffer walkouts in industrial labor dispute, Reuters says »

Approximately 44,000…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOLD

Amicus

$15.78

0.71 (4.71%)

12:45
01/18/18
01/18
12:45
01/18/18
12:45
Options
Amicus call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JPM

JPMorgan

$113.44

0.45 (0.40%)

12:41
01/18/18
01/18
12:41
01/18/18
12:41
Periodicals
JPMorgan sued for over $875M by Nigeria over 2011 oilfield deal, Reuters reports »

JPMorgan has been sued…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

  • 27

    Feb

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

FSNN

Fusion Telecommunications

$3.83

-0.03 (-0.78%)

12:33
01/18/18
01/18
12:33
01/18/18
12:33
Hot Stocks
Cooper Creek Partners reports 5.17% passive stake in Fusion Telecommunications »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,295.00

-9.86 (-0.76%)

, MS

Morgan Stanley

$55.59

0.235 (0.42%)

12:29
01/18/18
01/18
12:29
01/18/18
12:29
General news
On The Fly: Top stock stories at midday »

Stock futures were above…

AMZN

Amazon.com

$1,295.00

-9.86 (-0.76%)

MS

Morgan Stanley

$55.59

0.235 (0.42%)

LGF.A

Lionsgate

$34.99

2.71 (8.40%)

CBS

CBS

$61.09

2.19 (3.72%)

VIAB

Viacom

$31.96

0.58 (1.85%)

VIA

Viacom

$37.85

0.95 (2.57%)

GNC

GNC Holdings

$4.95

1.48 (42.65%)

PTC

PTC

$66.70

1.41 (2.16%)

AA

Alcoa

$52.37

-4.6199 (-8.11%)

ENDP

Endo

$7.69

-0.32 (-4.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

  • 18

    Jan

  • 18

    Jan

  • 19

    Jan

  • 08

    Feb

  • 08

    Feb

  • 08

    Feb

  • 15

    Feb

  • 18

    Mar

IP

International Paper

$62.23

0.74 (1.20%)

12:25
01/18/18
01/18
12:25
01/18/18
12:25
Options
International Paper call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

FMC

FMC Corporation

$88.41

-5.45 (-5.81%)

12:23
01/18/18
01/18
12:23
01/18/18
12:23
Recommendations
FMC Corporation analyst commentary  »

FMC Corporation pullback…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

  • 07

    Mar

BBBY

Bed Bath & Beyond

$23.40

0.39 (1.69%)

12:21
01/18/18
01/18
12:21
01/18/18
12:21
Hot Stocks
Bed Bath & Beyond recalls Hudson Comforters on mold exposure 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COLB

Columbia Banking

$45.94

0.36 (0.79%)

12:19
01/18/18
01/18
12:19
01/18/18
12:19
Hot Stocks
Columbia Bank names Lisa Dow chief risk officer »

Columbia Bank announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Mar

ACOR

Acorda Therapeutics

$24.75

-0.3 (-1.20%)

12:17
01/18/18
01/18
12:17
01/18/18
12:17
Periodicals
Acorda Therapeutics jumps after web report about takeover approach »

According to a report…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

12:17
01/18/18
01/18
12:17
01/18/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
01/18/18
01/18
12:16
01/18/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:15
01/18/18
01/18
12:15
01/18/18
12:15
General news
Atlanta Fed's Q4 GDPNow estimate was raised to 3.4%: »

Atlanta Fed's Q4…

AMZN

Amazon.com

$1,295.00

-9.86 (-0.76%)

, SNE

Sony

$49.18

-0.6438 (-1.29%)

12:12
01/18/18
01/18
12:12
01/18/18
12:12
Periodicals
Amazon looks to compete in commercial films, less indies, Reuters says »

Amazon (AMZN) is looking…

AMZN

Amazon.com

$1,295.00

-9.86 (-0.76%)

SNE

Sony

$49.18

-0.6438 (-1.29%)

FOX

21st Century Fox

$36.49

0.7 (1.96%)

TWX

Time Warner

$92.31

0.14 (0.15%)

VIA

Viacom

$37.85

0.95 (2.57%)

CMCSA

Comcast

$41.68

-0.14 (-0.33%)

DIS

Disney

$111.33

-0.64 (-0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

  • 19

    Jan

  • 24

    Jan

  • 06

    Feb

  • 07

    Feb

  • 08

    Feb

  • 18

    Mar

MELI

MercadoLibre

$340.45

0.6 (0.18%)

12:10
01/18/18
01/18
12:10
01/18/18
12:10
Options
$45.5M option print in MercadoLibre »

$45.5M option print in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FMC

FMC Corporation

$87.26

-6.6001 (-7.03%)

, SQM

SQM

$57.76

-1.79 (-3.01%)

12:06
01/18/18
01/18
12:06
01/18/18
12:06
Recommendations
FMC Corporation, SQM analyst commentary  »

FMC Corporation selloff…

FMC

FMC Corporation

$87.26

-6.6001 (-7.03%)

SQM

SQM

$57.76

-1.79 (-3.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

  • 07

    Mar

AXP

American Express

$100.20

-0.56 (-0.56%)

, V

Visa

$122.37

0.39 (0.32%)

12:06
01/18/18
01/18
12:06
01/18/18
12:06
Earnings
On The Fly: What to watch in credit card space earnings reports »

American Express (AXP) is…

AXP

American Express

$100.20

-0.56 (-0.56%)

V

Visa

$122.37

0.39 (0.32%)

MA

MasterCard

$164.92

0.6 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 01

    Feb

  • 01

    Feb

DIS

Disney

$111.22

-0.75 (-0.67%)

12:03
01/18/18
01/18
12:03
01/18/18
12:03
Hot Stocks
Disney, Twitch announce multi-year content partnership »

Social video service…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

  • 06

    Feb

INTC

Intel

$44.39

1.25 (2.90%)

12:01
01/18/18
01/18
12:01
01/18/18
12:01
Hot Stocks
Intel debuts technologies, including RealSense Volumetric Content Capture »

During the 2018 Sundance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 25

    Jan

FMC

FMC Corporation

$87.26

-6.6 (-7.03%)

, SQM

SQM

$57.49

-2.065 (-3.47%)

12:00
01/18/18
01/18
12:00
01/18/18
12:00
Recommendations
FMC Corporation, SQM analyst commentary  »

FMC Corporation pullback…

FMC

FMC Corporation

$87.26

-6.6 (-7.03%)

SQM

SQM

$57.49

-2.065 (-3.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

  • 07

    Mar

SBAC

SBA Communications

$161.47

1.62 (1.01%)

12:00
01/18/18
01/18
12:00
01/18/18
12:00
Options
One-day put sellers in SBA Comm »

One-day put sellers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGF.A

Lionsgate

$33.90

1.62 (5.02%)

, CBS

CBS

$61.09

2.19 (3.72%)

11:58
01/18/18
01/18
11:58
01/18/18
11:58
Hot Stocks
Lionsgate jumps after report on potential takeover interest »

Shares of Lionsgate…

LGF.A

Lionsgate

$33.90

1.62 (5.02%)

CBS

CBS

$61.09

2.19 (3.72%)

VIAB

Viacom

$31.96

0.58 (1.85%)

VIA

Viacom

$37.85

0.95 (2.57%)

AMZN

Amazon.com

$1,295.00

-9.86 (-0.76%)

VZ

Verizon

$52.78

1.055 (2.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

  • 19

    Jan

  • 23

    Jan

  • 08

    Feb

  • 08

    Feb

  • 08

    Feb

  • 15

    Feb

  • 18

    Mar

ADP

ADP

$122.05

2.66 (2.23%)

, CSOD

Cornerstone OnDemand

$39.28

0.34 (0.87%)

11:52
01/18/18
01/18
11:52
01/18/18
11:52
Conference/Events
Stephens enterprise software analyst holds analyst/industry conference call »

Enterprise Software…

ADP

ADP

$122.05

2.66 (2.23%)

CSOD

Cornerstone OnDemand

$39.28

0.34 (0.87%)

MSFT

Microsoft

$90.14

1.79 (2.03%)

ORCL

Oracle

$50.26

-0.01 (-0.02%)

PAYC

Paycom

$88.34

-0.01 (-0.01%)

PCTY

Paylocity

$49.46

0.71 (1.46%)

SAP

SAP

$111.45

0.2601 (0.23%)

ULTI

Ultimate Software

$226.26

3.48 (1.56%)

WDAY

Workday

$112.26

2.17 (1.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 22

    Jan

  • 26

    Jan

  • 31

    Jan

  • 31

    Jan

  • 06

    Feb

  • 06

    Feb

  • 07

    Feb

  • 13

    Feb

  • 26

    Feb

  • 13

    Mar

  • 14

    Mar

DXCM

Dexcom

$56.32

-0.09 (-0.16%)

, ABT

Abbott

$58.77

-0.22 (-0.37%)

11:51
01/18/18
01/18
11:51
01/18/18
11:51
Hot Stocks
Dexcom dips with Cigna deeming Abbott's Libre medically necessary »

Shares of Dexcom (DXCM)…Reference Link

DXCM

Dexcom

$56.32

-0.09 (-0.16%)

ABT

Abbott

$58.77

-0.22 (-0.37%)

CI

Cigna

$218.45

-1.915 (-0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 01

    Feb

  • 26

    Feb

  • 27

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.